Výsledky vyhledávání - "Howard E. Rockette"

Akademický článek

Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis

Autor: Chester V. Oddis, Howard E. Rockette, Lei Zhu, Diane C. Koontz, David Lacomis, Swamy Venturupalli, Siamak Moghadam‐Kia, Dana P. Ascherman, Leslie Crofford, Mazen M. Dimachkie, Floranne Ernste, David Gazeley, Galina Marder, Rohit Aggarwal

Publikováno v: ACR Open Rheumatology, Vol 4, Iss 11, Pp 983-990 (2022)

Objective To assess the efficacy and tolerability of tocilizumab in a multicenter, randomized, double‐blind, placebo‐controlled trial in refractory adult patients with dermatomyositis (DM) and polymyositis (PM). Methods Thirty‐six subjects with

Externí odkaz: https://doaj.org/article/3f29f397a65a46d68d5dc727acfb139e

Zobrazit plný text záznamu

Akademický článek

Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis.

Autor: Farrel J Buchinsky, Joseph Donfack, Craig S Derkay, Sukgi S Choi, Stephen F Conley, Charles M Myer, John E McClay, Paolo Campisi, Brian J Wiatrak, Steven E Sobol, John M Schweinfurth, Domingos H Tsuji, Fen Z Hu, Howard E Rockette, Garth D Ehrlich, J Christopher Post

Publikováno v: PLoS ONE, Vol 3, Iss 5, p e2263 (2008)

RRP is a devastating disease in which papillomas in the airway cause hoarseness and breathing difficulty. The disease is caused by human papillomavirus (HPV) 6 or 11 and is very variable. Patients undergo multiple surgeries to maintain a patent airwa

Externí odkaz: https://doaj.org/article/bf7099225aaa4631b311c4be2cb3d544

Zobrazit plný text záznamu

Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children

Autor: Thomas G. Lynch, Stan L. Block, Jennifer P. Nagg, D. Kathleen Colborn, Howard E. Rockette, Diana H. Kearney, Susan J. Copelli, John J. Labella, Nader Shaikh, Alejandro Hoberman, Michael Green, MaryAnn Haralam, Marcia Kurs-Lasky, Timothy R. Shope, Norman L. Cohen, Marcia A. Pope, Judith M. Martin, Sonika Bhatnagar, Jack L. Paradise

Publikováno v: New England Journal of Medicine. 375:2446-2456

Limiting the duration of antimicrobial treatment constitutes a potential strategy to reduce the risk of antimicrobial resistance among children with acute otitis media.We assigned 520 children, 6 to 23 months of age, with acute otitis media to receiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a92bcc4468b87d39ec2bfa657d9db4a5
https://doi.org/10.1056/nejmoa1606043

Zobrazit plný text záznamu

Stopping rules for long-term clinical trials based on two consecutive rejections of the null hypothesis

Autor: Mohamed Mubasher, Howard E. Rockette

Publikováno v: Communications in Statistics - Theory and Methods. 46:1342-1351

A strategy for stopping long-term randomized clinical trials with time-to-event as a primary outcome measure has been considered using the criteria requiring multiple consecutive (or non consecutive) rejections at a specified α-level that controls a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::42499fa06d1b346eceac7d11dba0af79
https://doi.org/10.1080/03610926.2015.1019142

Zobrazit plný text záznamu

Reduced-Concentration Clavulanate for Young Children with Acute Otitis Media

Autor: Alejandro Hoberman, Raman Venkataramanan, Judith M. Martin, Jennifer P. Nagg, Diana H. Kearney, Howard E. Rockette, Marcia A. Pope, Gysella Muniz, Mohammad K. Miah, Sonika Bhatnagar, Jack L. Paradise, Marcia Kurs-Lasky, Jan H. Beumer, Mary Ann Haralam, Timothy R. Shope, Wenchen Zhao, Jong-Hyeon Jeong, Nader Shaikh

Publikováno v: Antimicrobial agents and chemotherapy. 61(7)

Amoxicillin-clavulanate (A/C) is currently the most effective oral antimicrobial in treating children with acute otitis media (AOM), but the standard dosage of 90 mg amoxicillin/6.4 mg clavulanate/kg of body weight/day commonly causes diarrhea. We ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36e1d8229f3b5b228cee709d73e3a380
https://pubmed.ncbi.nlm.nih.gov/29269433

Zobrazit plný text záznamu

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial

Autor: Chester V, Oddis, Ann M, Reed, Rohit, Aggarwal, Lisa G, Rider, Dana P, Ascherman, Marc C, Levesque, Richard J, Barohn, Brian M, Feldman, Michael O, Harris-Love, Diane C, Koontz, Noreen, Fertig, Stephanie S, Kelley, Sherrie L, Pryber, Frederick W, Miller, Howard E, Rockette, David, Sherry

Publikováno v: Arthritis & Rheumatism. 65:314-324

The idiopathic inflammatory myopathies (IIM) are a heterogeneous group of acquired disorders characterized by chronic inflammation of striated muscle leading to predominantly proximal muscle weakness. The most common subsets of IIM include adult poly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::052c72390d8947082c007f79e953384a
https://doi.org/10.1002/art.37754

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání